Press Releases
Keyword Search
08.10.23
OpGen Reports Second Quarter 2023 Financial Results and Provides Business Update
08.07.23
OpGen’s Subsidiary Ares Genetics Releases New Features to its AREScloud Offering
08.03.23
OpGen’s Subsidiary Curetis and FIND Extend R&D Collaboration Agreement
08.03.23
OpGen to Provide Business Update and Financial Results for the Second Quarter 2023 on August 10th at 4:30 p.m. Eastern Time
07.19.23
OpGen’s Subsidiary Curetis Meets Milestones of Extended and Expanded R&D Collaboration with FIND
06.26.23
OpGen Subsidiary Ares Genetics Successfully Maintains Key Patent under Opposition in Europe
06.22.23
OpGen’s Subsidiary Curetis Receives Batch of Ten New C-Series Unyvero A30 Instruments
06.20.23
OpGen Presents Unyvero Urinary Tract Infection Panel Trial Results at ASM Microbe 2023 Conference
05.15.23
OpGen Reports First Quarter 2023 Financial Results and Provides Business Update
05.08.23
OpGen to Provide Business Update and Financial Results for the First Quarter 2023 on May 15th at 4:30 p.m. Eastern Time